fda compounding glp-1 Warns on Certain Forms of Compounded Semaglutide FDA Proposes Ending Large-Scale GLP-1
Description
Lifestyle Changes: Direct Comparison Lets break down the outcomes of GLP-1 medications and lifestyle changes side by side
Olivera offers a safer, legal and affordable path to care through its medical weight-loss Chicago GLP-1 program
October 24th, 2025: New Study Links Ozempic to Potential Risk of Vision Loss A new study has identified a possible association between Ozempic and non-arteritic anterior ischemic optic neuropathy (NAION), a rare eye condition that can cause sudden and permanent vision loss

Known Side Effects and Safety Concerns Despite their benefits, GLP-1 receptor agonists are not without side effects

While this is uncommon, it underscores the critical importance of maintaining hydration during treatment
